Related by context. All words. (Click for frequent words.) 72 Novel Therapeutics 72 Clinical Trial Results 71 RNAi Therapeutics 71 Long Awaited Reality 70 Phase 2b Clinical Trial 70 Autoimmune Disease 70 Cancer Stem Cells 69 Inflammatory Diseases 69 Novel Antibiotic 69 Inflammatory Disease 69 Therapeutic Vaccines 69 Hematological Malignancies 69 Cancer Therapies 69 Metabolic Disease 68 HCV Protease Inhibitor 68 Novel Therapies 68 Antibody Therapeutics 68 Protein Therapeutics 68 ASM Biodefense 68 Anticancer Drug 68 Inflammatory Arthritis 68 Hematologic Malignancies 68 Autoimmune Diseases 68 RNAi Therapeutic 68 Oral Fingolimod 67 Retrovirus 67 Gastric Cancer 67 Oncologic 67 Oral Presentations 67 Targeted Therapies 67 Personalised Medicine 67 Cell Transplant 67 Malignant Melanoma 67 Tumor Microenvironment 67 Myelodysplastic Syndromes 67 Neurodegenerative Disease 67 Monoclonal Antibodies 67 Immunotherapeutic 67 Neural Stem Cells 67 Biological Therapy 66 Molecular Pathogenesis 66 Pulmonary Arterial Hypertension 66 Chronic Myeloid Leukemia 66 Small Molecule 66 Cancer Vaccines 66 Hepatocellular Carcinoma 66 Therapeutic Antibody 66 Stem Cell Transplant 66 Bladder Cancer 66 Viral Infections 66 Tuberculosis Vaccine 66 Novel Antibody 66 RNA Therapeutics 66 Preclinical Development 66 Prenatal Diagnosis 66 Cancer Therapeutic 66 Neurodegenerative Diseases 66 Novel Approaches 66 Therapeutic Targets 66 Gastrointestinal Oncology 66 Prolongs Survival 66 Nuclear Receptors 66 Renal Cancer 66 Nicotine Vaccine 66 Molecular Mechanisms 66 Hepatitis C Virus 66 Dendritic Cells 66 Anticancer Agent 66 Kinase Inhibitor 66 Bone Marrow Transplantation 65 Initiates Clinical 65 Patient Enrollment 65 Cytometry 65 Therapeutic Potential 65 Genetic Disorders 65 RNA Interference 65 Investigational Drug 65 Phase 2b Trial 65 Advanced Melanoma 65 Successfully Completes Phase 65 Preclinical Models 65 M.D. Ph.D. 65 Phase III Clinical Trial 65 Molecular Diagnostic 65 Male Infertility 65 Image Guided 65 Preclinical Data 65 Clinical Outcomes 65 Kinase Inhibitors 65 Oral Presentation 65 Clinical Outcome 65 High Throughput Biology 65 Metabolic Disorders 65 Integrative Neuroscience 65 Preclinical Studies 65 Molecular Basis 65 Vascular Targeting Agents 65 Recombinant Protein 65 Cancer Biomarkers 65 Biomarker Discovery 65 Combination REOLYSIN R 65 Prostate Cancer Vaccine 65 Tumor Biology 65 Epilepsy Surgery 65 Preclinical Study 65 Pulmonary Hypertension 65 Clostridium difficile Infection 65 Cellular Immunology 65 Therapeutic Antibodies 65 Completes Patient Enrollment 64 Initiates Phase III 64 Islet Transplantation 64 Inflammatory Bowel Diseases 64 Drug Shows Promise 64 Novel Therapeutic 64 Vaccine Adjuvant 64 Receives Milestone Payment 64 Anti Infective 64 Synthetic Peptide 64 VARI Laboratory 64 Alvine Pharmaceuticals 64 Nanobiotechnology 64 Emerging Therapies 64 Cancer Immunotherapeutics 64 Poster Presentations 64 Presents Positive 64 Late Breaker 64 Liver Cancer 64 Metastatic Melanoma 64 Initiates Clinical Trial 64 Malignant Mesothelioma 64 Investigational Compound 64 Phase III Trial 64 Cell Differentiation 64 Malaria Vaccine 64 Mitochondrial Medicine 64 Meets Primary Endpoint 64 Tyrosine Kinase Inhibitor 64 ERYtech 64 Molecular Virology 64 Renal Cell Carcinoma 64 Neurodegenerative 64 BIO InvestorForum 64 Anticancer Activity 64 Cambridge Healthtech Institute 64 Gene Silencing 64 Phase III Pivotal 64 Immunotherapeutics 64 Severe Asthma 64 Photodynamic Therapy 64 Protein Expression 64 Metastatic Cancer 64 Molecular Diagnostic Test 64 Laryngeal Cancer 64 NIH Vaccine 64 Molecular Medicine Tri 64 Nerve Regeneration 64 Solid Tumors 64 Vicor Technologies 64 Bipolar Disorders 64 Radiopharmaceutical 64 Neurodegenerative Disorders 64 Protein Involved 64 Immune Mediated 63 Cardiac Stem Cell 63 Presents Preclinical Data 63 Genes Predict 63 Acute Heart Failure 63 Lupus Nephritis 63 Early Diagnosis 63 Biomarker 63 ASCO GI 63 Combination Therapy 63 Adult Stem Cell Therapy 63 Inflammatory Markers 63 Chronic Lymphocytic Leukemia 63 Neural Stem Cell 63 Tissue Engineering 63 Multidrug Resistant 63 Gastrointestinal Cancers 63 Files IND 63 Novel Vaccine 63 Survival Benefit 63 Novel Mechanism 63 Neurotherapeutics 63 Phase IIb Clinical Trial 63 Blood Cancers 63 Phase 2b Study 63 Therapeutic Vaccine 63 II Clinical Trial 63 Receives Orphan Drug Designation 63 Cardiovascular Therapeutics 63 Toxicogenomics 63 Previously Treated 63 Protein Interaction 63 Completes Enrollment 63 See CLINICAL PHARMACOLOGY 63 Immunomedics Announces 63 Randomized Double blind 63 Molecular Diagnostics 63 Pathogenesis 63 Randomized Controlled 63 Neuroprotection 63 Molecular Origins 63 Neoadjuvant Chemotherapy 63 Announces Poster Presentations 63 Commercialize Novel 63 Lung Cancer Drug 63 Diabetic Foot Ulcer 63 BiTE Antibody 63 siRNA Delivery 63 Genetic Testing 63 Pooled Analysis 63 Hematological 63 Initiates Phase II 63 Malignancies 63 Phase Ib Clinical Trial 63 Vaccine Trials 63 NCI Cancer 63 Improve Diagnosis 63 Biodefense Vaccines 63 Immunotherapies 63 Tissue Repair 63 Companion Diagnostics 63 Innate Immunity 63 Develops Novel 63 Rexahn Pharmaceuticals 63 Multicenter Trial 62 Relapsed Refractory 62 Clinical Evaluation 62 Poster Presentation 62 Novel Treatments 62 Non Invasive 62 Present Preclinical Data 62 Procyon Biopharma 62 Anti Tumor 62 Mouse Models 62 Sidney Kimmel Cancer 62 Hedgehog Pathway Inhibitor 62 Cellular Therapies 62 Nanoemulsion 62 Nucleic Acids 62 Medtech Insight Investment 62 Atopic Dermatitis 62 Diagnostic Immunology 62 Anticancer Compound 62 Relapsing Multiple Sclerosis 62 Urinary Incontinence 62 Neuro Oncology 62 Human Neural Stem 62 Antitumor Activity 62 Nymox NX 62 Treating Chronic 62 Female Urology 62 Controlled Study 62 Guidelines Recommend 62 Cell Lung Cancer 62 Maven Semantic 62 Cancer Treatments 62 Disease Modifying 62 Genes Involved 62 Biomarker Study 62 Therapeutic Competitors companiesandmarkets.com adEgemonye 62 Brentuximab Vedotin SGN 62 Avian Flu Vaccine 62 Double Blind Placebo 62 Pluristem Therapeutics 62 Patient Outcomes 62 Regado Biosciences 62 UCLA California NanoSystems 62 Vaccine Protects Against 62 Peripheral Blood 62 Antisense Drug 62 Migraine Drug 62 NGFN 62 Interventional Oncology 62 Antiviral Therapy 62 Multicenter Study 62 Neuroendocrine Tumor 62 Inhaled Liposomal Ciprofloxacin 62 Cardiometabolic 62 Monoclonal Antibody 62 Oral Cavity 62 Meta Analysis 62 Immune Cell 62 Neoplasia 62 Cellular Therapy 62 Translational Genomics 62 Advanced Pancreatic Cancer 62 Pathogen Detection 62 Lupus Drug 62 Insulin Resistance 62 Antibody Discovery 62 Anti Angiogenesis 62 Ovarian Cancer Patients 62 Hematologic Oncology 62 Randomized Phase III 62 IND Filing 62 Oligonucleotides 62 Solid Malignancies 62 Initiates Enrollment 62 Oral Calcitonin 62 Autoimmunity 62 Antibody Drug Conjugate 62 Rotavirus Vaccine 62 Anti Angiogenic 62 Investigational Treatment 62 Postdoctoral Position 62 ARRY # 62 #:#-#,# [003] 62 Exploratory Clinical 62 Lung Cancer Trial 62 Kidney Transplant Patients 62 Coronary Revascularization 62 Immune Disease 62 Breast Cancer Treatment 62 Drug Eluting 62 Kidney Transplantation 62 Collaborators Publish 62 Shows Promising 62 Newly Diagnosed 62 Biopharmaceutical Industry 62 Pivotal Trial 62 Stem Cell Treatment 62 Severe Sepsis 62 Study Evaluating 62 Randomized Double Blind Placebo 62 Cell Signalling 62 Begins Dosing 62 Mammalian Cells 62 Novel Oral 62 Oncogene 62 Lung Cancers 62 Initiate Phase 62 Fungal Infections 62 Gout Drug 62 Collaborators Present 62 Crit Rev 62 Advanced Prostate Cancer 62 Phase 2a Clinical Trial 62 Eye Diseases 62 Viral Disease 62 Renal Anemia 62 Brain Tumors 62 Combination Treatment 62 Prostate Cancer Treatment 62 Therapeutic Competitors Companies 62 Orphan Diseases 62 Psoriasis Patients 62 Systemic Sclerosis 62 Chicago Multidisciplinary Symposium 62 Genomic Analysis 62 Tissue Regeneration 62 NASDAQ LIPD 62 Therapeutic Approaches 62 Treatment Shows Promise 62 Pandemic Influenza Vaccines 62 Minimally Invasive Treatment 62 Dermatologic 62 Adenoma 62 Rheumatoid Arthritis Patients 61 Biochemical Genetics 61 Needham Biotechnology 61 Adjuvant Breast Cancer 61 MorphoSys AG FSE MOR 61 Potent Antiviral Activity 61 Slow Progression 61 Stem Cell Transplants 61 Daniel Von Hoff 61 Powell Gene Therapy 61 Epeius Biotechnologies Corporation 61 Pediatric Oncology Branch 61 Hsp# Inhibitor 61 Carotid Stenting 61 Anti Infectives 61 Develop Novel 61 Bone Metastases 61 ANN INTERN MED 61 First Patient Dosed 61 antibody blinatumomab MT#/MEDI-# 61 Regenerative Cells 61 Successfully Treated 61 Preterm Labor 61 ASCO Breast Cancer 61 Breast Oncology 61 Lung Cancer Survival 61 Vulnerable Plaque 61 MEK Inhibitor 61 Cardiovascular Imaging 61 Small Molecules 61 Molecular Therapy 61 Vitro Activity 61 BIOCOM Investor Conference 61 Initiate Clinical Trial 61 Completes Patient Enrolment 61 Stem Cell Transplantation 61 Multiple Myeloma Patients 61 Phase III Trials 61 Randomized Phase 61 FOLOTYN ® 61 Mouse Model 61 Prostate Disease 61 Developmental Genetics 61 IL# PE#QQR 61 Interstitial Cystitis 61 Randomized Double Blind 61 Randomized Study 61 Canaccord Adams Hepatitis C 61 Reports Preclinical Data 61 Bipolar Depression 61 Quark Pharmaceuticals 61 Multicenter Phase 61 HER2 Positive 61 Clinical Translational 61 Therapeutic Competitors 61 Hormone Refractory Prostate Cancer 61 First Patient Enrolled 61 Anthrax Toxin 61 SWX RO SWX ROG 61 Shown Effective 61 Investigator Initiated 61 Ebola Vaccine 61 Ocular Disease 61 Genetic Diseases 61 MassGeneral Institute 61 Microbicide 61 Male Contraceptive 61 Valve Replacement 61 Sapacitabine 61 Complicated Skin 61 Shows Promise Against 61 Protein Interactions 61 Artificial Pancreas 61 Anti CD# Antibody 61 Taxane 61 Liver Disease 61 Statin Therapy 61 Hedgehog Pathway 61 Therapeutic Agents 61 Therapeutics TCT 61 Prospective Randomized 61 Venous Thromboembolism 61 Receives Orphan Drug 61 Clinical Therapeutics 61 Prostate Cancer Patients 61 Motility 61 Pediatric Diabetes 61 Antibiotic Resistance 61 Neural Repair 61 Genes Identified 61 Acute Ischemic Stroke 61 Pivotal Phase III 61 Aggressive Reduction 61 DNA Methylation 61 Cutaneous T 61 Seasonal Influenza Vaccine 61 Pediatric Bipolar Disorder 61 Recombinant Human 61 Phase IIb Trial 61 Influenza Virus 61 Molecular Oncology 61 Breast Ultrasound 61 Soft Tissue Sarcoma 61 Treatment Algorithm 61 Systemic Delivery 61 Clinical Proteomics 61 Migraine Treatment 61 Investigational Agent 61 Immunodeficiency 61 Treating Depression 61 Circulating Tumor Cells 61 Preclinical Evaluation 61 Am J Geriatr 61 Hormone Receptor Positive 61 HDAC Inhibitor 61 Personalized Immunotherapy 61 Chronic Hepatitis C 61 Tyrosine Kinase Inhibitors 61 Placebo Controlled Study 61 NovaBay Pharmaceuticals 61 DIRECT Trial 61 Treatment Reduces 61 J Allergy Clin 61 Postmenopausal Women 61 Leukemia Lymphoma 61 Antigen Specific 61 J Clin 61 Cardiac Rhythm 61 Bayhill Therapeutics 61 Cardiovascular Disease Risk 61 Upcoming Investor 61 Childhood Diseases 61 Neurochemistry 61 Improves Survival 61 Thoracic Oncology 61 EORTC NCI 61 Adjuvant Chemotherapy 61 Discoveries Tomorrow 61 DNA Sequencing 61 Phase Ib II 61 Phase 1b Clinical Trial 61 Transdermal Delivery 61 Effective Treatments 61 NanoBioTechnology 61 BioCentury Future Leaders 61 Cutaneous Oncology 61 Clinical Efficacy 61 Computational Genomics 61 Max Delbrück Center 61 Lumbar Spine 61 Neuropathic Pain 61 Stem Cell Therapies 61 Phase 2a Trial 61 Stomach Cancer 61 Abstract Accepted 61 Pivotal Study 61 Pelvic Surgery 61 Smooth Muscle 61 Molecular Cancer 61 Previously Untreated 61 Liver Tumors 60 Cell Transplants 60 Dose Ranging Study 60 Drug Discovery 60 Clinical Trials 60 Monoclonal antibody 60 Prostate Cancers 60 Improve Survival 60 Psoriasis Drug 60 Demonstrates Sustained 60 Nasdaq HALO 60 Phase III Clinical Trials 60 Anticancer Agents 60 Patients Treated With 60 ImmunoCellular Therapeutics 60 Drug Candidate 60 Safinamide 60 Advanced Renal Cell 60 Rigshospitalet Copenhagen Denmark 60 Complete Remission 60 NOVAVAX 60 Drug Prevents 60 Newly Diagnosed Patients 60 Hematopoietic Stem Cell Transplantation 60 Influenza Vaccine 60 Protein Biomarker 60 Molecular Therapeutics 60 Uterine Fibroid Embolization 60 Sangamo BioSciences Announces 60 Molecular Carcinogenesis 60 Randomized Phase II 60 Renal Cell Cancer 60 Oncolytic 60 Pancreas Cancer 60 pralatrexate injection folate analogue 60 Myeloma Patients 60 Bacterial Cell 60 Arthritis Musculoskeletal 60 AACR Meeting 60 Mimetics 60 Oral Formulation 60 Treatment Naive Patients 60 ICAAC IDSA 60 Estrogen Therapy 60 Osteoporosis Treatment 60 Whole Genome Sequencing 60 Cancer Vaccine 60 NABTT 60 Semafore Pharmaceuticals 60 Biologics Manufacturing 60 Treatment Naïve 60 Rheumatoid Arthritis Drug 60 Bone Marrow Transplants 60 Shows Efficacy 60 Renal Tumors 60 Cholesterol Levels SPARCL 60 Neuroimmunology 60 Radiation Treatment 60 Dose Escalation 60 Berlin Buch Germany 60 Mitral Valve Repair 60 #nd EORTC NCI 60 Chemoprevention 60 Awarded Qualifying Therapeutic 60 transthyretin TTR mediated amyloidosis 60 Urologic Cancer 60 Immunobiology 60 Companion Diagnostic 60 Completes Dosing 60 rPA Anthrax Vaccine 60 Hospital Acquired Pneumonia 60 Regenerative Therapies 60 ASH Annual Meeting 60 Myelodysplastic Syndrome MDS 60 Breast Cancer Cells 60 Vaccine Adjuvants 60 Frankfurt XMP 60 OTCBB IMUC 60 Drug Fails 60 Advanced Colorectal Cancer 60 Neurological Disease 60 Prospective Multicenter 60 Biotherapeutics 60 Advanced Ovarian Cancer 60 Genetic Variation 60 TB Vaccine 60 Colorectal Cancer Patients 60 Vaccine Immunology 60 Surgical Treatment 60 Oral Insulin Capsule 60 ChinaBio ® 60 Antipsychotic Drug 60 Cardiotoxicity 60 Cedars Sinai Regenerative Medicine 60 Protein Kinases 60 AASLD Meeting 60 Human Embryonic Stem 60 Myocardial Ischemia 60 Tomorrow Cures 60 Mesoblast Limited ASX MSB 60 Glycobiology 60 Hematology Molecular Pathology 60 Antibody Engineering 60 Immunotherapy 60 AMEX RGN 60 Pharmacogenomics 60 Antithrombotic 60 Tumor Targeting 60 Skeletal Muscle 60 Ceflatonin R 60 Beneficial Effects 60 Solid Tumor 60 Select Biosciences 60 Artificial Liver 60 Neuromuscular Disorders 60 Magnetic Nanoparticles 60 J Neurosurg 60 Hepatitis C Treatment 60 Endothelial Cells 60 CROI 60 Omacetaxine 60 Bone Marrow Stem Cells 60 Ion Channels 60 Pharmacogenomic 60 ST Elevation Myocardial 60 Milestone Payment 60 Anthracycline 60 Phytomedics Inc. 60 Experimental Hematology 60 Epidemiological Studies Unit 60 Chemotherapeutic Agents 60 VentiRx Pharmaceuticals 60 Minimally Invasive Therapy 60 Functional Neurosurgery 60 Metastatic Colorectal Cancer 60 Therapeutics TCT scientific 60 Metastatic Prostate Cancer 60 ECTRIMS 60 JAK Inhibitor 60 Enrolling Patients 60 Well Tolerated 60 Cardiovascular Risk Reduction 60 Inflammatory Bowel Disease 60 Cell Signaling 60 Cardioxyl Pharmaceuticals 60 Artificial Organs 60 Neck Cancer 60 Survivorship Program 60 Endovascular Repair 60 Retroviral 60 Uterine Fibroids 60 Liver Metastases 60 Non Invasive Treatment 60 Vaccine Candidate 60 Pre Exposure Prophylaxis 60 Study Showed 60 Provectus Pharmaceuticals specializes 60 Pink Sheets RHHBY 60 Embryonic Stem 60 Antiviral Drugs 60 Synthetic Chemistry 60 Neurovirology 60 Lung Injury 60 Thyroid Cancer 60 Therapeutic Effects 60 Stakeholder Opinions 60 Chronic Hepatitis B 60 Slows Progression 60 EnVivo Pharmaceuticals 60 Fixed Dose 60 Targeted Therapy 60 UCSF Diabetes 60 Aptamer 60 Idenix Pharmaceuticals 60 Mantle Cell Lymphoma 60 Neurorehabilitation 60 Pemphigus Vulgaris 60 Molecular Cell Biology 60 Minimally Invasive Surgical 60 Colorectal Cancers 60 Tissue Engineered 60 Prognostic Value 60 Nuvelo Announces 60 HER2 Positive Breast Cancer 60 Neuroanatomy 60 Aflibercept 60 Refractory Angina 60 MGH Cancer 60 SIX RO ROG 60 Patients Enrolled 60 Respiratory Virus 60 Epiphany Biosciences 59 Annu Rev 59 Progenitor Cells 59 Lung Cancer Patients 59 Overactive Bladder 59 Nanostructured Materials 59 Membrane Protein 59 Granted Orphan Drug 59 Regeneron Pharma 59 AACR San Antonio 59 Dr. Rafick Pierre 59 Pirfenidone 59 Diagnostic Tests 59 ALN TTR 59 GTCbio 59 Catheter Ablation 59 Hematological Cancers 59 Heart Failure Patients 59 Drug Formulation 59 Genocea Biosciences 59 MMR Vaccine 59 Biotherapeutic 59 Bionanotechnology 59 Initiates Phase 2b 59 Vector Borne 59 InNexus Biotechnology 59 Hematology Meeting 59 Cedars Sinai Maxine Dunitz 59 Technological Advances 59 Preclinical Efficacy 59 Castration Resistant Prostate Cancer 59 J.P. Morgan Healthcare 59 Therapeutics Roundtable 59 recurrent glioma 59 Topline Results 59 Anti Tumor Activity 59 Chronic Sinusitis 59 Metastatic Breast Cancer 59 entitled Formulary Advantages 59 Clinical Trials Update 59 Pivotal Phase 59 Contrast Agents 59 Newly Diagnosed Breast Cancer 59 GVAX ® 59 Platelet Inhibition 59 Left Ventricular Dysfunction 59 Demonstrates Efficacy 59 Drug Metabolism 59 Mucosal Immunology 59 Anticancer Drugs 59 ExL Pharma 59 SCIB1 59 Interventional Cardiovascular 59 Tumor Immunology 59 Thromb Haemost 59 Autoimmune Disorders 59 Clinical Trial Data 59 Drug Pipeline 59 Novel Compounds 59 Preclinical Testing 59 Resolvyx Pharmaceuticals 59 Fast Skeletal Troponin 59 Physiology Seminar 59 Thyroid Hormone 59 ENESTnd 59 Enlarged Prostate 59 Single Molecule 59 Romiplostim 59 Therapeutic Efficacy 59 Metastatic Colon Cancer 59 Randomized Trials 59 JAK2 Inhibitor 59 Asthma COPD 59 Patients Suffering 59 Breast Cancer Patients 59 Cervical Dysplasia 59 Founding Scientist 59 Antiplatelet Therapy 59 Eluting Stent 59 HORIZONS AMI 59 Carotid Endarterectomy 59 Novartis Molecular Diagnostics 59 Schizophrenia Treatment 59 Experimental Vaccine 59 Cardiovascular Outcomes 59 Bioimaging 59 Pluripotent Stem Cells 59 Brain Disorders 59 NanoBio Corporation 59 Diasome 59 Bioprocess 59 Curr Opin 59 Islet Transplant 59 Molecular Genetics Laboratory 59 Antiviral Activity 59 Systematic Review 59 Randomized Clinical Trial 59 Pivotal Clinical Trial 59 Localized Prostate Cancer 59 Plaque Psoriasis 59 Metabolic Bone Diseases 59 Diabetic Nephropathy 59 Outcome Sciences 59 Benign Prostatic Hyperplasia 59 Glucosamine Chondroitin Arthritis 59 Subgroup Analysis 59 Interventional Neuroradiology 59 Drug Resistant Tuberculosis 59 Chronic Lymphocytic Leukemia CLL 59 AACR IASLC Joint 59 Prostate Cancer Screening 59 Hepatic Encephalopathy 59 Breast Brachytherapy 59 Ozarelix 59 Drug Combo 59 Pharmacogenetics 59 Submits IND 59 Nasdaq NPSP 59 Sipuleucel T 59 Urologic Oncology 59 Lymphoid 59 NIAID Vaccine Research 59 Myeloproliferative Disorders 59 Xcytrin R 59 Significantly Improved 59 Patient Oriented 59 Tesetaxel 59 Efficacious 59 Afferent Pharmaceuticals 59 Gender Differences 59 Retrovirology 59 Tezampanel 59 FoldRx Pharmaceuticals Inc. 59 BiTE R 59 Erectile Dysfunction Drug 59 PhD MGH 59 #:#-# [001] 59 J Clin Endocrinol Metab 59 Fibromyalgia Syndrome 59 Knee Osteoarthritis 59 First Patient Treated 59 Deforolimus 59 Romidepsin 59 Obstet Gynecol 59 Cannabinoid 59 Genetic Variations 59 Allogeneic 59 Genetic Disease 59 Genetic Markers 59 Uterine Cancer 59 Genitourinary Cancers Symposium 59 Translational Biology 59 UEGW 59 Presents Preclinical 59 Heart Failure Treatment 59 Renal Transplantation 59 Glufosfamide 59 Fondaparinux 59 SABCS 59 KL4 Surfactant 59 Biomolecules 59 Developmental Therapeutics 59 Nitazoxanide 59 Fabry Disease 59 Breaking Clinical Trials 59 Valvular Heart Disease 59 Specialty Pharma 59 Brain Plasticity 59 oncolytic virus therapies 59 Colorectal Cancer CRC 59 Epithelium 59 Proteomics 59 Metabolomics 59 Demonstrates Significant 59 Diabetic Neuropathy 59 Macromolecular 59 Cellular Tissue 59 AGY Therapeutics 59 VitiGam 59 Medical Research Katholic 59 Immunogenetics 59 Manja Bouman CEO 59 PharmaVitae Profile 59 Thomas Ichim 59 Metabolic Diseases 59 Hepatitis B Vaccine 59 Sinus Infections 59 Dupuytren Contracture 59 Prophylactic Treatment 59 Initiates Dosing 59 Stereotactic Radiosurgery 59 Confirms Efficacy 59 Therapy Improves 59 Bio Pharmaceutical 59 Stent Thrombosis 59 Disease Diagnosis 59 Breast Cancer Metastasis 59 Translational Neuroscience 59 Ridaforolimus 59 Demonstrates Potent 59 Clinical Virology 59 Pharmacyclics Announces 59 Oral Mucositis 59 Gynecological Cancer 59 Breast Tumors 59 Phase 2a Study 59 Universal Flu Vaccine 59 Adult Stem Cell 59 PRNewswire FirstCall Pharmacopeia 59 #:#-#,# CrossRef Medline [002] 59 Biomaterial 59 Lipid Sciences 59 ARVO 59 Proves Effective 59 Gene Linked 59 Autologous Stem Cell Transplantation 59 Endocrine Society Annual Meeting 59 Molecular Epidemiology 59 Aliskiren 59 Pharmacoepidemiology 59 Optical Tweezers 59 Technological Innovations 59 Recurrent Breast Cancer 59 Prolexys 59 Neurosurg 59 Nasal Powder 59 Lung Cancer Treatment 59 REMINDER ORLive Presents 59 Randomized Clinical Trials 59 Immune Responses 59 Cognitive Deficits 59 Poster Discussion 59 Novel Small Molecule 59 Long Term Survival 59 Signal Transduction 59 Improves Outcomes 59 OTCBB EMIS 59 ImmunoVaccine Technologies 59 Toxicity Testing 59 Topical Treatment 59 Molecular Evolution 59 Protein Folding 59 Intravenous Formulation 59 Adjuvant Treatment 59 Placebo Controlled Trial 59 Gastrointestinal Cancer 59 Unresectable 59 Endometrial Cancer 59 Demonstrates Ability 59 ASCO GU 59 Initiate Phase III 58 Tumor Suppressor Gene 58 Submits Response 58 Diabet Med 58 Prognostic Significance 58 Multicenter Randomized 58 Hyperthermia Therapy 58 Inc Therapeutic Competitors 58 Idiopathic Pulmonary Fibrosis 58 Biomanufacturing 58 BioBusiness.TV 58 Synthetic Biology 58 Improve Patient Outcomes 58 NIAID Laboratory 58 Adult Stem Cells 58 Small Molecule Drug 58 Cancer Therapy 58 Improve Outcomes 58 Immune Cells 58 Arthritis Drug 58 Malignancy 58 Tesmilifene 58 Bundesministerium für Bildung und 58 Tropical Diseases NITD 58 Valopicitabine 58 Osteoarthritis Patients 58 Arch Neurol 58 UM Comprehensive Cancer 58 CRLX# 58 Dementias 58 Drug Resistant 58 NHGRI Division 58 OTCBB CVBT 58 ABRF 58 Phase IIa Clinical Trial 58 Gene Expression Profiling 58 Br J Haematol 58 Pharmacology Toxicology